U.S. markets closed
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • Dow 30

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • Russell 2000

    2,237.75
    -49.71 (-2.17%)
     
  • Crude Oil

    71.50
    +0.46 (+0.65%)
     
  • Gold

    1,763.90
    -10.90 (-0.61%)
     
  • Silver

    25.84
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1865
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • USD/JPY

    110.1500
    -0.0810 (-0.07%)
     
  • BTC-USD

    35,764.17
    +264.80 (+0.75%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Nuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details

·2 min read

MISSISSAUGA, ON, Nov. 2, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2020 financial results before markets open on Monday, November 16, 2020.

Nuvo Pharmaceuticals Inc. (CNW Group/Nuvo Pharmaceuticals Inc.)
Nuvo Pharmaceuticals Inc. (CNW Group/Nuvo Pharmaceuticals Inc.)

The Company will subsequently hold a conference call the same day, Monday, November 16, 2020 at 8:30 a.m. ET, hosted by Jesse Ledger, Nuvo's President & Chief Executive Officer and other senior management. A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS

DATE:

Monday, November 16, 2020



TIME:

8:30 a.m. ET



DIAL-IN NUMBER:

416 764 8688 or 1 888 390 0546



TAPED REPLAY:

416 764 8677 or 1 888 390 0541 / REPLAY PASSCODE: 499774#

The audio webcast can be accessed at:

https://produceredition.webcasts.com/starthere.jsp?ei=1387608&tp_key=8417e4c6b2

An archived replay of the webcast will be available by clicking the link above.

About Nuvo Pharmaceuticals Inc.
Nuvo (TSX: NRI; OTCQX: NRIFF) is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Nuvo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the U.S. Food and Drug Administration (FDA), Health Canada and E.U. approved manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the FDA. For additional information, please visit www.nuvopharmaceuticals.com.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvo-pharmaceuticals-announces-third-quarter-2020-results-release-date-and-conference-call-details-301164339.html

SOURCE Nuvo Pharmaceuticals Inc.